Newsletter | July 15, 2026

07.15.26 -- Driving Leadership And Metrics From The Manufacturing Floor

INDUSTRY INSIGHTS

The Evolution Of Parenteral Manufacturing For Sensitive Drugs

Parenteral manufacturing is advancing with better facilities, single‑use systems, continuous processing, and Annex 1 compliance to meet demand for specialised biologics and personalized therapies.

4 Reasons For The Rise In Blister Packaging

Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

Biocatalysis 101: Faster, Greener API Manufacturing

View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support sustainable processes.

FEATURED EDITORIAL

Driving Leadership And Metrics From The Manufacturing Floor

After graduating with a biology degree from Howard University and entering the pharma industry, Stephanie Wimberly found herself the only woman — the only black woman — in a manufacturing facility in Maryland. A supervisor made it clear he didn’t want her on his team; she was reassigned to the night shift at her facility. “I had a family to support, and night shift, or abuse, was not what I signed up for,” she says. “But I didn’t have many options.” Here is how she persevered, and prospered.

Why Contamination Control By Design Should Matter To Your CDMO

EU GMP Annex 1 mandates a documented contamination control strategy, and FDA expectations are substantively equivalent. Let's look at why CDMOs are disproportionately exposed.

INDUSTRY INSIGHTS CONTINUED

A Live Q&A With The Scientists Reimagining ASD Manufacturing

Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

Efficient Biologics Manufacturing

See how experts provide an overview of how advanced mammalian cell culture platforms enable efficient, scalable biopharmaceutical development and manufacturing.

Optimizing Product Packaging And Oral Drug Delivery With Stick Packs

Adopt stick pack technology to deliver precise, patient-centric oral doses that enhance adherence, streamline manufacturing, and support scalable, compliant pharmaceutical packaging.

SOLUTIONS

A Bridge To Global Small Molecule Manufacturing

Formulation Development Services

PBPK Predictive Modeling Services

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: